سعر تريكسام Trexam‏ 500مجم 20 اقراص 2026

Trexam (tranexamic acid) 500 mg tablets, pack of 20 (2 strips), by Memphis (Egypt).

• Rare: colour vision disturbances, retinal/artery occlusion, thromboembolic events, allergic skin reactions; very rare: hypersensitivity including anaphylaxis, arterial or venous thrombosis, digestive effects (nausea, vomiting, diarrhoea) that disappear when the dose is reduced; frequency not known: convulsions, fixed drug eruption, acute renal cortical necrosis.International label, same formulation · electronic medicines compendium (emc)

• Severe renal impairment (risk of accumulation).International label, same formulation · electronic medicines compendium (emc)
• Hypersensitivity to tranexamic acid or excipients.International label, same formulation · electronic medicines compendium (emc)
• Active thromboembolic disease; history of venous or arterial thrombosis.International label, same formulation · electronic medicines compendium (emc)

• Haematuria of renal origin carries a risk of urinary obstruction; monitor closely.International label, same formulation · electronic medicines compendium (emc)
• Use with care in women on oral contraceptives because of increased thrombosis risk; patients with thrombophilia only with strong indication under strict supervision.International label, same formulation · electronic medicines compendium (emc)
• Irregular menstrual bleeding: establish the cause before use.International label, same formulation · electronic medicines compendium (emc)

• Fibrinolytic (thrombolytic) agentsTrexamamic acid counteracts the thrombolytic effect of fibrinolytic preparations.electronic medicines compendium (emc)
• Combined hormonal contraceptivesUS label: concomitant use is contraindicated because of thromboembolic risk.DailyMed (U.S. National Library of Medicine)

• No evidence of teratogenicity in animal studies, but the usual caution should be observed; tranexamic acid crosses the placenta.International label, same formulation · electronic medicines compendium (emc)
• Passes into breast milk at about one hundredth of the maternal blood concentration; an antifibrinolytic effect in the infant is unlikely.International label, same formulation · electronic medicines compendium (emc)